These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6290350)

  • 1. Cytosolic estrogen and progestin receptors in human endometrium from different regions of the uterus.
    Kauppila A; Jänne O; Stenbäck F; Vihko R
    Gynecol Oncol; 1982 Oct; 14(2):225-9. PubMed ID: 6290350
    [No Abstract]   [Full Text] [Related]  

  • 2. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
    Jänne O; Kauppila A; Kontula K; Syrjälä P; Vihko R
    Int J Cancer; 1979 Nov; 24(5):545-54. PubMed ID: 231013
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgen, estrogen and progestin cytosol receptor concentrations in the normal human endometrium. Effects of intrauterine device.
    Punnonen R; Pettersson K; Vanharanta R
    Gynecol Obstet Invest; 1984; 17(2):73-7. PubMed ID: 6323283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin modulation of estrogen-dependent marker protein synthesis in the endometrium.
    DeSombre ER; Kuivanen PC
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):6-11. PubMed ID: 3975654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.
    Gunderson CC; Dutta S; Fader AN; Maniar KP; Nasseri-Nik N; Bristow RE; Diaz-Montes TP; Palermo R; Kurman RJ
    Gynecol Oncol; 2014 Jan; 132(1):33-7. PubMed ID: 24316307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
    Vierikko P; Kauppila A; Vihko R
    Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of various analytical methods for the estimation of hormone receptor parameters in reproductive tissues.
    Rojas FJ; Moretti-Rojas I; de Bellabarba G; Bishop W
    Acta Cient Venez; 1981; 32(4):330-7. PubMed ID: 6328813
    [No Abstract]   [Full Text] [Related]  

  • 9. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
    Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
    Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues.
    Bergeron C; Ferenczy A; Shyamala G
    Lab Invest; 1988 Mar; 58(3):338-45. PubMed ID: 3347010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid receptors in normal, hyperplastic and malignant human endometria.
    Vihko R; Jänne O; Kauppila A
    Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine and ovarian estrogen receptor levels in climacteric women.
    Punnonen R; Kouvonen I; Lövgren T; Rauramo L
    Acta Obstet Gynecol Scand; 1979; 58(4):389-91. PubMed ID: 525273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of estrogen/progestogen receptors in the endometrium.
    Casper RF
    Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
    King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
    J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin therapy for perimenopausal women.
    Kase NG
    J Reprod Med; 1982 Aug; 27(8 Suppl):522-30. PubMed ID: 7131445
    [No Abstract]   [Full Text] [Related]  

  • 18. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia.
    Miranda MC; Mazur MT
    Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple extractions of hormone receptor from rabbit uteri and human breast tumors.
    Chen YM; Rice RG; Vaughn CB
    Anticancer Res; 1985; 5(4):363-7. PubMed ID: 2994550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
    King RJ
    Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.